
December 23, 2022
Melanoma Immunotherapy with GPR182 blockade
Description: Immune checkpoint inhibitor therapy has greatly improved survival of patients with late-stage melanoma. However, about 2/3 of patients do not benefit from this...
Learn more about our upcoming Galas and Signature Events Learn More
Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community New York City, NY (September 11, 2025) – The...
Description: Immune checkpoint inhibitor therapy has greatly improved survival of patients with late-stage melanoma. However, about 2/3 of patients do not benefit from this...
Oct 16, 2025 ET
Oct 30, 2025 ET